Combined Rosiglitazone and Forskolin Have Neuroprotective Effects in SD Rats after Spinal Cord Injury

Figure 5

The mRNA and protein expression of MAP2, NeuN, and NF-κB. The ELISA results of PKA. (a) Relative MAP2 mRNA expression levels. (b) Relative NeuN mRNA expression level. (c) Relative NF-κB mRNA expression level. (d) Relative MAP2 protein expression level. (e) Relative NeuN protein expression level. (f) Relative NF-κB protein expression level. (g) Representative western blots showing the effects of rosiglitazone, forskolin, and forskolin + rosiglitazone on MAP2, NF-κB, and NeuN. (h) PKA expression levels detected by ELISA. Data were expressed as means±SD (n = 3). Each experiment was repeated at least three times. P < 0.05 compared with vehicle group. # P < 0.05, compared with the forskolin + rosiglitazone group.